@article{6042b2f6c5114bdeac0e4cd560b3f3f9,
title = "Primary and mental health service use in community health center patients before and after cancer diagnosis",
abstract = "Background: Cancer survivors face increased risk for chronic diseases resulting from cancer, preexisting conditions, and cancer treatment. Having an established primary care clinic or health insurance may influence patients{\textquoteright} receipt of recommended preventive care necessary to manage, treat, or diagnose new conditions. This study sought to understand receipt of healthcare in community health centers (CHCs) before and after cancer diagnosis among cancer survivors. We also examined the type of care received and assessed whether being established with a CHC or the type of health insurance affected the use of services. Methods: Using electronic health record data and linked cancer registries from 5,649 CHC patients in three states from 2012 through 2018, we obtained monthly rates of primary care and mental health/behavioral health (MHBH) visits and the probability of receipt of care before and after a cancer diagnosis. Results: Seventy-five percent of CHC patients diagnosed with cancer returned to their primary CHC for care within 2-years of their diagnosis. Among those who returned, there was a sharp increase in primary and MHBH care shortly before their diagnosis. Significantly more primary care (pre: 19.6%, post: 21.9%, p < 0.001) and MHBH care (pre: 1.2%, post: 1.6%, p < 0.001) was received after diagnosis than before. However, uninsured patients had fewer visits after their diagnosis than before. Conclusion: Use of preventive care for cancer survivors is particularly important. Having an established primary care clinic may help to ensure survivors receive recommended screening and care.",
keywords = "cancer survivors, community health centers, health care disparities, preventive services, utilization of health services",
author = "Larson, {Annie E.} and Heather Angier and Andrew Suchocki and Voss, {Robert W.} and Miguel Marino and Nathaniel Warren and Nathalie Huguet",
note = "Funding Information: This work was conducted with the Accelerating Data Value Across a National Community Health Center Network (ADVANCE) Clinical Research Network (CRN). OCHIN leads the ADVANCE network in partnership with Health Choice Network, Fenway Health, and Oregon Health & Science University. ADVANCE is funded through the Patient‐Centered Outcomes Research Institute (PCORI), contract number RI‐CRN‐2020‐001. This research article is in part based on cancer data provided by the Oregon State Cancer Registry (OSCaR), the California Cancer Registry, and the Washington State Cancer Registry (WSCR), participating registries funded by the National Program of Cancer Registries (NPCR) under the Centers for Disease Control and Prevention (CDC). We wish to thank Julianne Cooley with California Cancer Reporting and Epidemiologic Surveillance (CalCARES), Todd Beran with OSCaR, and Mahesh Keitheri Cherteri with WSCR for their assistance with data linkage and file preparation. Funding Information: This publication was supported by the National Health, Lung, and Blood Institute grant number R01HL136575 and by the National Cancer Institute grant number R01CA204267. Funding Information: This publication was supported by the National Health, Lung, and Blood Institute grant number R01HL136575 and by the National Cancer Institute grant number R01CA204267. This work was conducted with the Accelerating Data Value Across a National Community Health Center Network (ADVANCE) Clinical Research Network (CRN). OCHIN leads the ADVANCE network in partnership with Health Choice Network, Fenway Health, and Oregon Health & Science University. ADVANCE is funded through the Patient-Centered Outcomes Research Institute (PCORI), contract number RI-CRN-2020-001. This research article is in part based on cancer data provided by the Oregon State Cancer Registry (OSCaR), the California Cancer Registry, and the Washington State Cancer Registry (WSCR), participating registries funded by the National Program of Cancer Registries (NPCR) under the Centers for Disease Control and Prevention (CDC). We wish to thank Julianne Cooley with California Cancer Reporting and Epidemiologic Surveillance (CalCARES), Todd Beran with OSCaR, and Mahesh Keitheri Cherteri with WSCR for their assistance with data linkage and file preparation. Publisher Copyright: {\textcopyright} 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.",
year = "2022",
month = jun,
doi = "10.1002/cam4.4524",
language = "English (US)",
volume = "11",
pages = "2320--2328",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "11",
}